论文部分内容阅读
目的探讨阿奇霉素序贯治疗对小儿支原体肺炎的疗效及炎性因子CRP的影响。方法将我院近3年来诊治的支原体肺炎患儿75例随机分为两组,对照组35例给予常规治疗,治疗组40例给予阿奇霉素静脉滴注及口服治疗,观察两组临床疗效及血清CRP水平的变化。结果治疗组临床总有效率为95.0%,明显高于对照组(P<0.05),治疗组临床症状及体征恢复时间和血清CRP水平改善程度均显著优于对照组(P<0.05)。结论阿奇霉素序贯治疗小儿支原体肺炎的疗效显著,可促进病情恢复,降低炎性因子CRP水平,值得临床推广。
Objective To investigate the effect of sequential treatment of azithromycin on children with mycoplasma pneumonia and the impact of inflammatory factor CRP. Methods 75 cases of mycoplasma pneumonia diagnosed and treated in our hospital in recent 3 years were randomly divided into two groups. 35 cases in the control group were given routine treatment. 40 cases in the treatment group were given azithromycin intravenously and orally. The clinical curative effect and serum CRP Horizontal changes. Results The total clinical effective rate was 95.0% in the treatment group, which was significantly higher than that in the control group (P <0.05). The clinical symptoms and signs recovery time and serum CRP level in the treatment group were significantly better than those in the control group (P <0.05). Conclusion Sequential azithromycin treatment of children with mycoplasma pneumonia significant effect, can promote the recovery of the condition, reduce the level of inflammatory factor CRP, worthy of clinical promotion.